Impact of controllability on pain and suffering by Löffler, Martin et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/painrpts
by
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3hIW
04IhZ9A
usclU
E
C
E
gX
lW
R
47sgLovJ/p5qovisQ
O
0E
=
on
10/28/2018
Downloadedfromhttps://journals.lww.com/painrptsbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3hIW04IhZ9AusclUECEgXlWR47sgLovJ/p5qovisQO0E=on10/28/2018
Psychology
Research Paper
Impact of controllability on pain and suffering
Martin Lo¨fflera, Sandra Kampinga, Michael Brunnera, Smadar Bustana,b,c, Dieter Kleinbo¨hla, Fernand Antonb,
Herta Flora,*
Abstract
Introduction: Chronic pain and pain-related suffering are major health problems. The lack of controllability of experienced pain
seems to greatly contribute to the extent of suffering. This study examined howcontrollability affects the perception of pain and pain-
related suffering, and the modulation of this effect by beliefs and emotions such as locus of control of reinforcement, pain
catastrophizing, and fear of pain.
Methods: Twenty-six healthy subjects received painful electric stimulation in both controllable and uncontrollable conditions. Visual
analogue scales and the “Pictorial Representation of Illness and Self Measure” were used to assess pain intensity, unpleasantness,
pain-related suffering, and the level of perceived control. We also investigated nonverbal indicators of pain and suffering such as
heart rate, skin conductance, and corrugator electromyogram.
Results: Controllability selectively reduced the experience of pain-related suffering, but did not affect pain intensity or pain
unpleasantness. This effect was modulated by chance locus of control but was unrelated to fear of pain or catastrophizing.
Physiological responseswere not affected by controllability. In a second sample of 25 participants, we varied the instruction. The effect
of controllability on pain-related suffering was only present when instructions focused on the person being able to stop the pain.
Discussion:Our data suggest that the additional measure of pain-related sufferingmay be important in the assessment of pain and
may be more susceptible to the effects of perceived control than pain intensity and unpleasantness. We also show that this effect
depends on personal involvement.
Keywords: Controllability, Pain, Suffering, Assessment, Locus of control
1. Introduction
Pain perception is modulated by cognitive and emotional
variables such as predictability,12,39 controllability,7,60 attentional
focus,1,48 or fear of pain.31,45,46 Studies in healthy volunteers
showed that controllable situations reduce pain intensity7,40,60
and unpleasantness7; however, controllability did not always
change pain perception.21,28,49 Although actual control wasmore
effective than perceived control alone in reducing pain,40 this
dissociation cannot fully explain these ambiguous findings
because exerted control did not reduce pain intensity59 and
perceived control was found to decrease pain intensity7 in other
studies. Anxiety,59 helplessness,60 or pain unpleasantness7 were
not assessed consistently across studies, although these
variables may modulate the effects of control on pain perception.
Carnevale13 suggested that suffering is the most important factor
that drives patients to seek medical attention. This is also true for
patients with chronic pain.3 Suffering is an overwhelming
experience, which is perceived when the intactness of the person
is threatened. Distress evoked by pain can induce suffering.
However, the meaning assigned to distressing events may vary
between persons, based on their personality and personal
history. Suffering correlates only moderately with fear and anxiety
where avoidance of a feared object prevails, whereas suffering
focusses on the self.8,14–16,54 We have demonstrated that pain-
related suffering is an additional component of pain that can be
assessed independently of pain intensity and unpleasantness.10
The lack of controllability might be especially important for the
experience of pain-related suffering in both experimental pain
studies and in patients.6,17 Ongoing but unsuccessful efforts to
influence the pain make patients especially vulnerable to
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suffering.56 In addition to observing the effects of control on verbal
reports of pain and suffering, a secondary goal of the studywas to
see if there are also effects on physiological indicators of pain and
suffering such as skin conductance responses (SCRs), corru-
gator electromyogram (EMG), and heart rate (HR).8 This would
indicate multilevel effects and would permit bias-free assess-
ments of pain and suffering also in groups that may not easily give
verbal reports such as children or incapacitated persons.
The effect of the experimental manipulation of controllability is
modulated by individual differences in the perception of control.
Wiech et al.59 reported that exerted control over painful
stimulation led to reduced pain perception in half of the subjects,
whereas the other half showed increased pain intensity ratings.
The authors hypothesized that the individuals’ locus of control
might explain these interindividual variations. We therefore
examined locus of control of reinforcement, which is the degree
to which people believe that they have control over the outcome
of positive or negative events in their lives as opposed to external
forces beyond their control.36,36,47 We hypothesized that an
internal locus of control would modulate higher effects of
uncontrollability on pain than an external or chance locus of
control.
The current study examined the influence of controllability on
pain intensity, unpleasantness, and pain-related suffering in 2
experiments that differed in the instructions that were used to
announce controllability. We hypothesized that control over pain
would positively affect all 3 dimensions, with the strongest
reduction related to suffering. We expected reductions in SCR
and EMG, but not HR. A high chance locus of control, the belief
that powerful others control one’s life, high catastrophizing, and
high fear of pain were assumed to reduce the positive effects of
perceived control on suffering.
2. Methods
2.1. Participants
Twenty-six right-handed subjects (13 male) between 18 and 43
years of age (mean: 25.5, SD 5 5.81) participated in the study
(sample 1). Twenty-five right-handed subjects (8 male) between
20 and 49 years of age (mean: 25.32, SD 5 5.79) participated in
study 2 (sample 2). Sample sizes were based on power
calculations to detect large effects (effect size d . 0.5) in
a within-subjects comparison, which have previously been
reported in a similar study design.60 The ethics committee of
the Medical Faculty Mannheim, University of Heidelberg, Ger-
many, approved the study, and written informed consent was
obtained from each participant. Exclusion criteria were cardio-
vascular or neurological disorders, brain injury, acute or chronic
pain, current use of pain medication, pregnancy, lifetime and
current substance abuse or dependence, and any other mental
disorders. The subjects were screened by a psychologist using
the German version of the Structured Clinical Interviews for the
Diagnostic and Statistical Manual IV (SCID)61 Axis I to exclude
subjects who fulfilled the criteria for a mental disorder.
2.2. Apparatus and application of painful stimuli
Pain processing was investigated in response to a series of
painful electrical stimuli applied under conditions of controllability
vs uncontrollability. A pair of subcutaneous needle electrodes
(20 mm long, 0.35-mm uninsulated tip, 2-mm2 stimulation area,
model: 9013R0272, 28G; Alpine Biomed ApS, Skovlunde,
Denmark) were placed at the left upper back, at the midtrapezius
muscle (1-mm needle separation). The stimulation site was
chosen to mimic a clinical condition, like chronic back pain as
closely as possible under experimental conditions and to allow
similar experiments in chronic back pain patients. Needle
electrodes mainly activating Ad fibers27 were chosen to elicit
a rapid and sharp painful sensation. The invasive character of
these needles was also expected to result in sufficiently high
suffering ratings to avoid floor effects in the rating data. Electric
stimuli (2 ms stimulus duration, 400 V, interstimulus interval 500
ms) were applied using a constant current stimulator (model
DS7A; Digitimer, Hertfordshire, England). The experiment was
performed using Presentation software (Version 14.0, http://
www.neurobs.com).
2.3. Psychophysical thresholds and stimulus calibration
The electrical stimulation parameters were determined individu-
ally, first by assessing pain-related thresholds by the method of
limits. For this purpose, perception threshold, pain threshold, and
pain tolerance were assessed during 4 ascending series of
electric stimuli. The participants were instructed to press a button
when they felt the stimulus for the first time (perception threshold),
when the stimulus was painful for the first time (pain threshold),
andwhen they could no longer tolerate the stimulus intensity (pain
tolerance). Each threshold was acquired once per ascending
series. The first ascending series was discarded as a practice trial,
to exclude early fatigue and/or sensitization. Thus, the average of
3 ratings per threshold served as the final parameter. A painful
stimulus intensity was preset at 70% of the interval between pain
threshold and pain tolerance.
Next, the painful stimulus intensity was adjusted to a perceived
pain intensity of 70% on a visual analogue scale (VAS) with the
endpoints “no pain” (0) to “extreme pain” (100). Magnitude
estimates of pain intensity were assessed during 3 test trials
(duration 10 seconds each). Stimulus intensity was adjusted to
reach a VAS rating of about 70%. The resulting individual stimulus
intensity of each subject was used for all further procedures
(sample 1: mean: 8.75, SD5 11.2; sample 2: mean: 10.35, SD5
18.38, values in mA).
2.4. Experimental procedure
We used a within-subjects design, where each subject received
painful electric stimulation in a controllable condition and an
uncontrollable condition. The experiment consisted of 4 blocks in
which participants received 8 series of painful stimulations (Fig.
1A). Each of the 4 blocks comprised 4 controllable and 4
uncontrollable trials, which were presented in an intermixed order
(randomized within each block).
In the controllable condition, the participants had the possibility
to stop the painful electric stimulation through a button press.
They were instructed to press the button when the stimulation
became intolerable. Painful stimulation continued until it was
ended by the participants. In the uncontrollable condition, the
participants were informed that the duration of the stimulation
was randomly determined by the computer. In reality, we used
a yoked control design to match the length of the stimulations in
the uncontrollable condition with those in the controllable
condition.60 The duration of the 4 uncontrollable trials was
predetermined by the duration of the 4 controllable trials of the
preceding block. The first block started with a controllable trial.
Durations of the uncontrollable trials of the first block were
predetermined randomly by one of the preceding controllable
trials of the same block. In all other blocks, the order of the trials
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was randomized. This led to comparable durations of the
controllable and uncontrollable trials (sample 1: controllable:
22.8 6 19.03 seconds, uncontrollable: 22.33 6 18.33 seconds;
sample 2: controllable: 16.9 6 15.05 seconds, uncontrollable:
18.26 15.28 seconds). The blocks were separated by 1-minute
breaks.
Due to our experimental manipulation, the exerted control had
to be accompanied by increased perceptions of control in the
controllable trials.We therefore assessed perceived controllability
of the pain during the controllability and uncontrollability trials after
each block of 8 trials. The same VASwas used for the controllable
and uncontrollable trials. The VAS was 800 pixels (23.5 cm) long
and ranged from “not at all controllable” to “extremely control-
lable,” with a visual angle of 16.7˚. The pixels were linearly
transformed to values of 0 to 100. Perceived controllability
differed significantly between the controllable and uncontrollable
conditions (sample 1: t(25) 5 12.91, P , 0.001, d 5 2.53 [CI95:
1.73–3.32]; sample 2: t(24) 5 6.96, P , 0.001, d 5 1.39 [CI95:
0.83–1.94]). The participants rated perceived controllability
higher when they were able to stop the stimulation compared
with the uncontrollable condition.
2.5. Instructions and trial structure
In each trial, the condition was announced on the computer
screen during a 4-second prestimulus time span. The stimulus
was expected during the following 6 seconds of an anticipa-
tion phase. Controllable trials were announced during the
prestimulus interval with the words: “SELF; please press the
button to terminate the stimulation.” Uncontrollable trials were
announced, for 4 seconds, with a slide stating: “COMPUTER;
stimulation will be terminated by the computer.” The assess-
ment of perceived stimulus intensity, unpleasantness, and
related suffering on a VAS, as well as the PRISM task, providing
an alternate estimate of suffering, was presented in random
order after each trial. The participants had a 32-second time
frame to rate all 4 scales, followed by a resting time span (off-
block) of 12 seconds.
2.6. Ratings
The assessment of pain intensity, unpleasantness, and suffering
was performed on horizontal VASs (800 pixels 5 235 mm) with
appropriate endpoints (pain intensity: “no pain” and “extreme
pain”; pain unpleasantness: “not unpleasant” and “extremely
unpleasant”; and suffering: “no suffering” and “extreme suffer-
ing”). The scales were presented on a computer screen and
comprised an angular view of 16.7˚. The VAS ratings were
transformed to values ranging from 0% to 100% of the distance
between the endpoints of the scale.
In the absence of a gold standard on how to measure
suffering,9 we complemented the “suffering” VAS with the
suffering scale implemented in the “Pictorial Representation of
Illness and Self Measure” (PRISM), because it performed best on
quality criteria compared with other instruments for measuring
suffering.35
Figure 1. Structure of the experiment: (A) The experiment consisted of 4 blocks with 8 stimulation trials each. In half of the cases, the stimulation could be stopped
by the participant (controllable condition). The remaining trials were stopped by the computer (uncontrollable condition). The duration of the self-controlled trials
equaled the duration of the computer-controlled trials in the subsequent block (dotted arrows). The order of the trials was randomized within each block. (B) Each
trial was announced by a slide that indicated the type of the trial. Note that in 25 participants, the word “self” was replaced by the word “button press” to announce
the controllable trials. The anticipation phase was followed by a varying interval of painful stimulation, ratings of pain intensity, pain unpleasantness, and pain-
related suffering. Each trial ended with an off-block lasting 12 seconds. ISI, interstimulus interval.
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The PRISM task was presented as a computerized version of
the original task. The participants viewed a gray screen with
a fixed yellow circle in the bottom right corner, representing their
self. Amoveable red circle was located in the center of the screen,
representing the current painful stimulation (corresponding to
“illness” in the original PRISM task). The participants were
instructed to estimate the importance of the painful stimulation
in their life by placing the red circle in an appropriate distance to
the yellow circle. According to the PRISM rationale, the amount of
suffering is coded by the inverse of the distance of the centers of
the red and yellow circles. Thus, the closer the red circle (painful
stimulation) is found in relation to the yellow circle (self), the higher
is the suffering felt under the aversive stimulation, whereas the
further the red circle is away from the yellow circle, the lower is the
suffering indicated. The raw PRISM scale values were linearly
transformed to values ranging from 0% to 100%, with 0%
representing no and 100% representing maximal suffering.
Before the experiment, all participants were asked whether
they were able to discriminate between the ratings. Because
suffering is a personal and individual experience conveying
multiple meanings that we did not want to delimit,14 no definition
was given to the participants. If the participants struggled with
differentiating between suffering and any of the pain scales, they
were asked: “Do you think one can suffer without being in
pain—can you give an example?” and “Do you think one can be in
pain without suffering—can you give an example?” All partic-
ipants confirmed those questions and were able to give
examples. If participants struggled with the discrimination of pain
intensity and pain unpleasantness, it was explained to them by
using the radio metaphor by Price et al.43 In this metaphor,
experiencing pain is compared with listening to the sound of
a radio, where pain intensity refers to the loudness of the music
and pain unpleasantness refers to the quality of themusic played.
The participants had a practice run for each rating before the
experiment commenced.
2.7. Adjustment of the experimental procedure
This experiment was initially performed in 26 participants. During
the debriefing session after the experiment, 4 participants
reported being confused by the overlap between the PRISM
rating and the instructions. The controllable trials were an-
nounced with the word “self,” whereas during the PRISM task,
the participants had to place a token of the painful stimulation in
relation to their self (yellow circle), with closer placements
representing higher suffering.
The participants stated that in the PRISM task, they were
confused between 2 possible meanings of the word “self” on the
display and did not know whether they were expected to rate the
amount of their own suffering (with ratings closer to the self,
indicating higher suffering) or how much they felt being the agent
in control of the previous stimulation (with ratings closer to the
self, indicating higher agency).
This instruction-related issue was not anticipated and there-
fore not systematically assessed in all participants. It can hence
not be ruled out that other participants were having the same
problem without reporting it. This renders a subsample analysis
impossible, and PRISM ratings in this sample should therefore be
interpreted with caution. To rule out this ambiguity, the
experiment was repeated in another 25 participants. For those
25 participants, the general instructions before the experiment
were changed and referred to controllable trials as “stoppable by
a button press.” Controllable trials were announced with a slide
stating: “BUTTON PRESS; please press the button to terminate
the stimulation” and uncontrollable trials with the following slide:
“COMPUTER; stimulation will be terminated by the computer”.
The data of the second experiment (sample 2) were analyzed in
the same way as the initial experiment (sample 1).
2.8. Questionnaires
Before the experiment, the participants completed the Locus of
Control Scale,34 which assesses beliefs about control of re-
inforcement with the subscales chance (IPC-C), control by
powerful others (IPC-P), and perceived mastery over one’s
personal life (IPC-I). The scale has good test–retest reliability (IPC-
I: r 5 0.55, IPC-P: r 5 0.66, and IPC-C: r 5 0.70), internal
consistency (a5 0.91 for IPC-I, a5 0.95 for IPC-P, and a5 0.9
for IPC-C), and validity.33 A general locus of control scale was
chosen becausewe examined healthy individuals, and the painful
stimulation was not related to any health problem.57
The participants also completed the Pain-Related Self State-
ments Scale (PRSS23), which assesses catastrophizing and
active coping. The scale is validated in German participants and
has excellent reliability (a5 0.92 for catastrophizing and a5 0.88
for active coping) and validity, as shown by significantly higher
values for pain catastrophizing and significantly lower values for
active coping in pain patients compared with healthy controls,
and low tomoderate correlationswith other pain-related variables
such as amount of daily activity, affective distress, or pain
severity.
Furthermore, the participants completed the Fear of Pain
Questionnaire (FPQ-III). The FPQ-III is a self-report measure
designed to evaluate fears about severe, minor, andmedical pain
with higher scores indicating more fear. The FPQ-III has shown to
be a valid and reliable instrument with good test–retest reliability,
predictive validity, and internal consistency (for severe pain: a 5
0.88, r5 0.69; for minor pain: a5 0.87, r5 0.73; and for medical
pain a5 0.87, r5 0.76)38,51 and has been validated in a German
population. The PRSS and FPQ-III were chosen to allow for
comparison with previous experimental work on pain-related
suffering8,10 and because they exist in validated German
versions.
2.9. Physiological assessments
Electromyography, SCRs, and electrocardiogram were recorded
and amplified using a BrainAmp ExG amplifier (Brain Products
GmbH, Mu¨nchen, Germany) and registered with a sampling
frequency of 500 Hz. The data in one participant had to be
discarded due to technical problems.
Electromyographic activity was recorded from the musculus
corrugator supercilii using small surface electrodes (1.5 mm Ag/
AgCl) that were placed in a bipolar fashion above the left eye,
using the placement recommended by Fridlund and Cacioppo.25
The SCRs were recorded from 2 electrodes (5 mm Ag/AgCl),
which were placed on the medial phalanges of digits III and IV of
the left hand.4 Skin conductance response analysis was
performed using the Ledalab V3.4.6c software package for
Matlab and followed the guidelines of Fowles et al.24 Electrocar-
diogram was recorded using two 7-mm Ag/AgCl electrodes
(Asmuth GmbH Medizintechnik, Minden, Germany), placed on
the subjects’ left lateral sternum at the upper and lower edges of
the musculus pectoralis major. The ground electrode was placed
on the right hip bone. Calculation of interbeat latencies and
artefact correction were performed by the KubiosHRV soft-
ware.53 Details on preprocessing of the physiological data can be
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found in the supplementary material (available at http://links.lww.
com/PR9/A34).
3. Statistical analyses
As explained in themethods section, 2 samples were assessed in
2 separate experimental runs, with differing instructions for the
controllability condition. In the original sample (sample 1), the
instructions referred to controllable trials as being stoppable by
the participant. In the sample of the second experiment (sample
2), the instructions were changed and referred to controllable
trials as “stoppable by a button press.” All results are reported for
both experimental runs. Statistical analyses were performed
using RStudio 1.0.143 (RStudio, Inc., Boston, MA) with R 3.4.0
(The R Foundation for Statistical Computing).
3.1. Controllability and its influence on pain and suffering
To test the specificity of the effect of controllability on suffering
compared with pain intensity and pain unpleasantness, we
used an analysis of variance (ANOVA) to examine the within-
subject effects of controllability (controllable vs uncontrolla-
ble) and rating dimension (intensity vs unpleasantness vs
suffering VAS vs PRISM). Effect sizes for the ANOVAs are
reported as partial h2, including 90% confidence intervals
(CIs) of the effect sizes. Confidence interval for partial h2 was
chosen following the recommendations by Steiger et al.52 for
one-sided tests (CI 5 100 [1 2 2a]%). Lower limits of the CIs
are reported as 0 in cases where the F test is not statistically
significant (a5 0.05). We used pairwise post hoc t tests (false
discovery rate, FDR-corrected5) to compare the VAS ratings
for perceived controllability, pain intensity, unpleasantness,
and suffering as well as PRISM ratings in the controllable and
uncontrollable conditions. Effect sizes for the t tests are
reported as Cohen’s d, including 95% CIs of the effect sizes.
Confidence interval for Cohen’s d was chosen following the
recommendations by Steiger et al.52 for two-sided tests (CI5
100 [1 2 a]%). Lower limits of the CIs are reported as ,0 and
upper limits as .0 in cases where the t test is not statistically
significant (a 5 0.05).
3.2. Individual differences in the effects of controllability on
pain and suffering
To explore the impact of locus of control, fear of pain, and pain
catastrophizing on the effect of controllability, the IPC, FPQ-III,
and PRSS subscales and the difference in ratings (controllable
minus uncontrollable) were correlated for each rating (intensity,
unpleasantness, suffering VAS, and PRISM).
3.3. Sample differences in the effects of controllability on
pain and suffering
To explore sample differences in the effect of controllability on the
ratings, we implemented separate ANOVAs for each rating
dimension (pain intensity, unpleasantness, suffering VAS, and
PRISM) to test the interaction of sample (sample 1 vs sample 2)
and controllability (controllable vs uncontrollable). To examine the
association of enduring beliefs and pain controllability, we
compared the correlations of the IPC, FPQ-III, and PRSS
subscales with differences in controllability (controllable minus
uncontrollable) between samples using Fisher’s z.
3.4. Physiological assessments
For details on statistical analysis of physiological data, see
supplementary material (available at http://links.lww.com/
PR9/A34).
4. Results
4.1. Controllability and its influence on pain and suffering
The ANOVAs using controllability (controllable vs uncontrollable)
and the rating dimension (intensity vs unpleasantness vs suffering
VAS vs PRISM) as within-subject effects were significant for rating
dimension (sample 1: F(3,75) 5 15.41, P , 0.001, h2 5 0.381
[CI90: 0.220–0.480]; sample 2: F(3,72) 5 24.47, P , 0.001, h
2 5
0.505 [CI90: 0.349–0.590]) with lower suffering than intensity and
unpleasantness ratings. The main effect of controllability was not
significant in this analysis (sample 1: F(1,25)5 0.40,P5 0.53,h25
0.016 [CI90: 0.000–0.159]; sample 2: F(1,24)5 0.93, P5 0.34, h
2
5 0.037 [CI90: 0.000–0.208]); however, we found a significant
interaction for controllability X rating dimension (sample 1: F(3,75)
5 6.59, P , 0.001, h2 5 0.209 [CI90: 0.066–0.312]; sample 2:
F(3,72) 5 5.69, P 5 0.001, h2 5 0.192 [CI90: 0.051–0.296]). This
illustrates a reduction of sufferingVAS (t(25)53.42,P5 0.008,d5
0.67 [CI95: 0.24–1.09]) in the controllable condition of sample 1,
which was not present in the intensity (t(25) 5 21.37, P 5 0.26,
d 5 0.27 [CI95: 20.12 to 0.66]), unpleasantness (t(25) 5 21.33,
P5 0.26,d5 0.26 [CI95:20.13 to 0.65]), andPRISM (t(25)5 0.31,
P 5 0.75, d 5 0.06 [CI95: 20.32 to 0.45]) ratings (Fig. 2A). For
sample 2, it illustrates an increase of unpleasantness ratings in the
controllable condition (t(24) 5 22.11, P 5 0.04, d 5 0.42 [CI95:
0.01–0.83]), which was not present in the intensity (t(24)521.76,
P 5 0.09, d 5 0.35 [CI95: 20.05 to 0.75]), suffering VAS (t(24) 5
0.78, P 5 0.44, d 5 20.16 [CI95: 20.55 to 0.24]), and PRISM
ratings (t(24) 5 0.18, P 5 0.85, d 5 0.04 [CI95: 20.35 to 0.43])
(Fig. 2B and Tables 1 and 2).
4.2. Individual differences in the effects of controllability on
pain and suffering
Subjects with a high chance-related locus of control showed
significantly more reduction in suffering VAS ratings in sample 1
(rp(24) 5 20.42, P 5 0.03), but less reduction in suffering VAS
(rp(23) 5 0.49, P 5 0.03) and suffering as assessed with the
PRISM (rp(23)5 0.53, P5 0.02) in sample 2 in the controllable vs
uncontrollable trials (Fig. 3). There was no significant influence of
chance-related locus of control on the effect of experimental
control for pain intensity (sample 1: rp(24) 5 20.38, P 5 0.08;
sample 2: rp(23) 5 0.35, P 5 0.08), unpleasantness (sample 1:
rp(24)520.28,P5 0.17; sample 2: rp(23)5 0.42,P5 0.05), and
also not for PRISM ratings in sample 1 (rp(24)520.02, P5 0.92).
There was no significant effect of internal locus of control, locus of
control directed to powerful others, catastrophizing, active
coping, or fear of minor, severe, or medical pain on the difference
between controllable and uncontrollable conditions (all r , 0.35,
P . 0.18).
4.3. Sample differences in the effects of controllability on
pain and suffering
There was no significant interaction of sample and controllability for
pain intensity (F(1,49) 5 0.28, P 5 0.60, h2 5 0.006 [CI90:
0.000–0.082]), unpleasantness (F(1,49) 5 1.18, P 5 0.28, h2 5
0.024 [CI90: 0.000–0.128]), suffering VAS (F(1,49)5 3.74, P5 0.06,
h25 0.071 [CI90: 0.000–0.203]), or PRISM ratings (F(1,49)5 0.01,
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P 5 0.93, h2 , 0.001 [CI90: 0.000–0.018]). The correlation of
chance-related locus of control with the difference in control-
lability ratings was significantly higher in sample 2 than in sample
1 for pain intensity (z 5 2.57, P 5 0.01), pain unpleasantness
(z 5 2.47, P 5 0.01), suffering VAS (z 5 3.30, P 5 0.001), and
PRISM ratings (z 5 2.05, P 5 0.04). The samples did not
significantly differ in any of the correlations between the rating
differences in pain intensity, pain unpleasantness, suffering
VAS, or PRISM with the subscales of the FPQ-III (all z , 1.72,
P . 0.08), PRSS (all z , 1.27, P . 0.20), or IPC-I and IPC-P
subscales (all z , 1.40, P . 0.15).
4.4. Physiological correlates of experimental controllability
We found a significant increase of SCR during painful stimulation
(F(2,50) 5 27.5, P , 0.001, h2 5 0.524 [CI90: 0.343–0.624]), an
HR deceleration during painful stimulation (F(2,50) 5 14.01, P ,
0.001, h2 5 0.359 [CI90: 0.169–0.484]), and an anticipatory
deceleration of corrugator EMG before the onset of painful
stimulation (F(2,50) 5 9.89, P , 0.001, h2 5 0.283 [CI90:
0.103–0.415]). None of the physiological measures differed
significantly between controllable and uncontrollable trials. For
further details on physiological data, see supplementary material
(available at http://links.lww.com/PR9/A34).
5. Discussion and conclusions
This study shows that control over pain primarily reduces the
degree of perceived suffering. This effect was modulated by the
subjects’ locus of control: The more participants attributed their
behavior to chance, the greater was the reduction of suffering
when they had control over their pain. Pain intensity and
unpleasantness ratings, by contrast, were unaffected by control
over pain. This effect was only present in the experiment initiated
by an instruction that focused on the person being able to stop
the pain. In a second experiment, where the instructions referred
to controllable trials as “stoppable by a button press,” suffering
was not influenced by controllability. Here, controllability
Figure 2. Effect of controllability on ratings in the original sample (A) and the second experiment (B): Bars show mean percentages of the pain intensity, pain
unpleasantness, suffering VAS, and PRISM ratings for the controllable condition (white) and the uncontrollable (black) condition, and error bars depict the standard
error of themean. Asterisks show significant repeated-measures t tests (controllable vs uncontrollable) with *P, 0.05 and **P, 0.01. VAS, visual analogue scale.
Table 1
Pain and suffering scales within experimental conditions: intensity, unpleasantness, suffering, and PRISM ratings and ratings of
perceived controllability are shown over all conditions and expressed as percentage values.
Sample Condition Sample
size (n)
Perceived
controllability,
M 6 SD
Intensity,
M 6 SD
Unpleasantness,
M 6 SD
Suffering,
M 6 SD
PRISM,
M 6 SD
Sample 1 Controllable 26 90.89 6 11.05 59.46 6 16.78 66.71 6 19.08 32.35 6 21.91 63.47 6 31.66
Uncontrollable 26 26.09 6 20.57 57.88 6 17.51 65.02 6 19.32 37.43 6 23.34 64.01 6 29.13
Significance *** n.s. n.s. ** n.s.
Sample 2 Controllable 25 84.83 6 13.11 62.34 6 17.62 62.14 6 18.63 30.16 6 19.7 69.02 6 26.85
Uncontrollable 25 41.56 6 28.17 59.8 6 17.41 57.89 6 18.36 31.27 6 19.93 69.34 6 25.96
Significance *** n.s. * n.s. n.s.
***P , 0.001, **P , 0.01, *P , 0.05, n.s.: P . 0.05.
M, mean.
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increased unpleasantness ratings, whereas pain intensity and
suffering remained unaffected. Interestingly, the modulation by
attribution to chance was inverse in this second sample: The
more participants attributed their behavior to chance, the smaller
was the reduction of suffering when they had control over their
pain.
5.1. Controllability and its influence on suffering
The finding that controllability reduces suffering extends the view
of the impact of controllability on the pain experience by ascribing
a key role to uncontrollability in the manifestation of suffering.
According to Thompson,54 the effects of control depend on the
meaning the individual ascribes to control, which matches the
view that the transition from pain to suffering results when
patients feel out of control, and that this transition is influenced by
the meaning the individual ascribes to the pain (eg, when chest
pain is mistaken as a life-threatening symptom by patients with
a panic disorder).15,30 Thus, perceived controllability may act as
an assurance that one will not face an event that is beyond the
limits of endurance, and suffering can be relieved by changing the
meaning of the pain3,14,44 to an experience that one can cope
with.
Our results could therefore shed a light on the inconsistencies
of previous studies, which examined the relationship of control-
lability and pain perception by relying exclusively on the pain
intensity and unpleasantness dimensions. Because previous
studies did not assess pain-related suffering, it is not clear to what
Figure 3. Impact of attributional style on the effects of control in the original sample (A) and the second experiment (B): the x-axis shows the chance subscale of the
IPC. The y axis shows the difference (D) in the suffering VAS ratings, depicted as percentage values. Ratings in the uncontrollable condition were subtracted from
ratings in the controllable condition. The black triangles depict the participants who indicated more suffering when pain could not be controlled. The gray triangles
depict participants who indicated more suffering when pain could be controlled. IPC-C, chance subscale of the internal, powerful others, and chance scale; VAS,
visual analogue scale. * P , 0.05.
Table 2
Correlations of attributional style, coping strategies, and fear of pain with differences in ratings (controllable minus uncontrollable) for
each rating (intensity, unpleasantness, suffering VAS, and PRISM).‡
Sample 1 Sample 2
Intensity Unpleasantness Suffering VAS PRISM Intensity Unpleasantness Suffering VAS PRISM
r(24); P r(24); P r(24); P r(24); P r(23); P r(23); P r(23); P r(23); P
IPC: Internal 20.18; 0.38 20.03; 0.86 0.2; 0.33 20.27; 0.19 0.06; 0.76 20.15; 0.76 20.21; 0.76 20.11; 0.76
IPC: Powerful others 20.23; 0.25 20.02; 0.91 20.16; 0.43 20.04; 0.86 0.06; 0.95 0.35; 0.33 0.01; 0.95 0.15; 0.92
IPC: Chance 20.38†; 0.08 20.28†; 0.17 0.42*†; 0.03 20.02†; 0.92 0.35; 0.08 0.42; 0.05 0.49*; 0.03 0.53*; 0.02
PRSS: Catastrophizing 20.13; 0.95 0.21; 0.95 20.01; 0.96 0.08; 0.95 20.08; 0.7 20.16; 0.61 20.16; 0.61 20.24; 0.61
PRSS: Coping 0.09; 0.87 0.22; 0.54 0.01; 0.96 20.25; 0.54 0.24; 0.38 0.26; 0.38 0.22; 0.38 20.02; 0.93
FPQ: Minor 20.23; 0.35 20.24; 0.35 20.27; 0.35 20.12; 0.55 20.04; 0.83 0.15; 0.63 0.23; 0.63 0.15; 0.63
FPQ: Severe 20.31; 0.47 20.1; 0.63 0.15; 0.62 20.2; 0.62 0.04; 0.86 0.12; 0.77 0.17; 0.77 0.15; 0.77
FPQ: Medical 20.13; 0.88 20.03; 0.88 20.11; 0.88 20.08; 0.88 20.22; 0.59 20.01; 0.95 0.25; 0.59 20.02; 0.95
Degrees of freedom are depicted at the top.
‡ Correlation coefficients (r ) and significance level (*P , 0.05, †significantly lower than the respective correlation in sample 2) are reported. Significant correlations are depicted in bold.
FPQ, Fear of Pain Questionnaire; IPC-C, internal, Powerful others, and Chance scale; PRSS, Pain-Related Self Statements Scale; VAS, visual analogue scale.
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extent these measures implicitly related to suffering. Depending
on the relevance of suffering for the given experimental setup,
pain relief,7,40,60 no changes,21,28,49 or in some cases even
increases in perceived pain50,59 may be obtained. The choice of
outcome measure is thus important for the detection of the
effects of controllability. Suffering has recently been proposed as
an outcome measure in patients with chronic pain in addition to
pain intensity and unpleasantness measures because it encom-
passes aspects of helplessness, hopelessness, and the feeling of
being overwhelmed.3
5.2. Controllability and its influence on pain unpleasantness
In the second study, the pain unpleasantness ratings in the
controllable condition were increased, and controllability was not
found to alleviate suffering. Testing for sample interaction effects
showed that the effects of controllability on pain and suffering did
not differ between the samples (Fig. 2). As reported above,
increased pain ratings in response to controllability have been
found before.50,59 Our experimental design was similar to the one
used in a study on brain mechanisms of pain controllability,60 but
did not implement a button press at the end of the uncontrollable
trials. This was included in the original study to account for motor
responses in the brain. This missing button press at the end of the
uncontrollable trials may have induced a different attentional state
as compared to the controllable trials. An attentive, but non-
reactive awareness was previously shown to reduce pain
unpleasantness.42
5.3. Locus of control and suffering
An external locus of control directed towards luck, fate, or chance
has been associated with maladaptive pain-coping strategies20
and higher levels of pain despite patient-controlled analgesia.29
Patients with chronic pain who attributed pain to chance
experienced pain more frequently and showed high pain intensity
ratings.11 Overall, chance locus of control might be associated
with less physical activity, more medication abuse, and higher
interference of pain in daily life.11 Internal locus of control, by
contrast, has been associated with positive outcomes such as
lower pain scores, higher satisfaction, and lower disability
levels.19,29
In sum, although an internal locus of control seems to be
a resilience factor against chronic pain,2,26 it does not seem to be
associated with pain perception in experimental pain.60 Rather,
attribution to chance seems to lead to worse outcome expect-
ations. Our results suggest that attribution to chance modulates
the effects of control over pain on pain-related suffering. Fear of
pain or pain catastrophizing did not modulate the effects of
control, which implies a specific effect of the attribution to chance.
In study 1, higher attribution to chance led to greater reduction
of suffering when pain could be controlled. However, in contrast
to these findings, we found the inverse relationship in our second
experiment. The circumstances under which controllability
reduces suffering therefore remain incompletely understood.
The 2 studies differed in the instructions given to the participants.
Instructional context and individual control beliefs may modulate
the effect; however, we cannot fully explain the exact interaction
effects. Future studies should therefore more stringently target
the modulatory effects of instructions on the effects of pain
controllability on suffering. In addition, cultural factors should be
considered because it has been shown that the influence of
external locus of control on affective symptoms is weaker for
collectivistic societies.18 Moreover, the meaning of suffering
differs between cultures and depends not only on the cultural
background of the patient but also on the cultural background of
the caregiver.22,37,58
5.4. Physiological correlates of experimental controllability
In this study, neither corrugator EMG nor SCR or HR were
affected by control over pain. This is in line with a study showing
that changes in SCR were not associated with the failure to
control pain.28 This study, however, also showed that changes in
HRwere associated with the failure to control pain. We previously
found that SCR and corrugator EMG, but not HR, were
associated with suffering.8 Given the explorative nature of our
hypothesis on physiological correlates of controllability effects
and the sensitivity of those effects to the modulation by individual
and contextual factors, there is a need for further research on this
issue. This should address the effects of perceived and exerted
control on physiological correlates or the modulatory effects of
personality.
5.5. Limitations
This study has several limitations. First, the instructions in our
experiment were not optimal for the use of the PRISM task. It
therefore cannot be ruled out that this ambiguity affected other
aspects of the experiment. However, because all reports of
ambiguity referred to and were limited to the PRISM rating, it is
unlikely that our results were biased by misunderstandings of
the instructions. A change of the instructions in a second
sample did not yield any changes in the effects of control on the
PRISM task. The PRISM task was developed and validated for
the application in health issues such as posttraumatic stress
disorder,62 lung disease, psoriasis, breast cancer,63 or chronic
urticaria.55 The sensitivity of the PRISM task in an experimental
setting with healthy individuals has not been tested, and
classic VAS measures seem to perform better in this task. A
second limitation of our study was the unclear significance of
the PRISM instructions for the participants. In both samples,
some people may have understood the instructions differently
from the others and this may have added additional variance.
In future studies, the instructions for the PRISM ratingsmust be
clarified. Third, the suffering VAS scores were rather low
compared with clinical settings. The experimental situation
does not fully resemble the suffering experienced in a clinical
pain condition and does not cover all existential aspects of the
suffering experience.32,41 Future studies are needed to
evaluate the translational value of our experimental findings
in clinical settings. Fourth, the sample effects that we observed
need to be addressed more stringently. In study 1, we
observed the opposite relationship between attribution to
chance and the effect of controllability on suffering compared
with study 2. This is a result that we had not predicted a priori
and should therefore be viewed as exploratory. A fifth limitation
relates to the number of variables tested in this study, which
increases the risk of chance findings. We tested the impact of
several individual difference variables on the effect of control-
lability. These results therefore need to be replicated. Finally,
we have made an attempt to disentangle the effects of
controllability on pain and pain-related suffering. We have,
however, not dissociated these effects from the effect of
controllability on fear, anxiety, or distress. These are related
variables and their modulation by controllability may confound
the effect of controllability on suffering.
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5.6. Conclusion
This study demonstrates that controllability primarily affects
suffering rather than pain severity or unpleasantness. In addition,
this result helps to understand the previous inconclusive findings
on the effect of controllability on pain. We propose a complex
interaction between individual control beliefs and instructional
context that influence the experience of suffering. Future studies
should take these factors into account when studying the effects
of controllability and assessing its significance in a clinical context.
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